PGM2L1 and neoplasm: Our findings revealed that PGM2L1 promotes the conversion of G-1-P (glycogen synthesis) to G-6-P (glycolysis) under hypoxic conditions, which is consistent with the metabolic tendency of tumor cells to favor glycolysis over the TCA cycle, thereby providing energy to sustain their malignant phenotype.